Background: Magnetoencephalography (MEG) can delineate critical regions of the cortex and facilitate conformal stereotactic radiosurgery (SRS) dose planning. Despite the substantial role of Gamma Knife® SRS in arteriovenous malformation (AVM) management, MEG-generated maps of critical regions have never been utilized to improve dose planning. Purpose: To assess the value of integrating functional brain mapping using MEG with dose planning during treatment of brain AVMs with SRS. Methods: This case series encompassed 5 patients with motor region AVMs. Noninvasive eloquent cortex mapping was achieved using a whole-head 306-channel Neuromag® Vectorview MEG System 5-10 days before SRS. On the day of SRS, the functional brain maps were integrated onto the intraoperative dose planning magnetic resonance imaging for Leksell GammaPlan® version 10. The median AVM volume treated was 12.7 cm3, and 18 Gy was the median margin dose. Results: Functional image integration of MEG improved the recognition of critical brain structures adjacent to the AVM. This facilitated anatomical planning designed to reduce the dose to adjacent critical structures while maintaining a therapeutic dose to the AVM target. The 5 patients had no adverse radiation effects during the follow-up. Conclusion: Coregistration of MEG data improves the accuracy and dose sparing needed for optimal planning during Gamma Knife SRS.

1.
Van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJE, van der Sprenkel JWB, Vandertop WP, Algra A, Klijn CJM: Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 2011;306:2011-2019.
2.
Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Jungreis CA, Maitz AH, Horton JA, Coffey RJ: Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991;75:512-524.
3.
Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD: An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother Oncol 2002;63:347-354.
4.
Monaco EA, Niranjan A, Kano H, Flickinger JC, Kondziolka D, Lunsford LD: Management of adverse radiation effects after radiosurgery for arteriovenous malformations. Prog Neurol Surg 2013;27:107-118.
5.
Niranjan A, Laing EJC, Laghari FJ, Richardson RM, Lunsford LD: Preoperative magnetoencephalographic sensory cortex mapping. Stereotact Funct Neurosurg 2013;91:314-322.
6.
Caramia F, Francia A, Mainero C, Tinelli E, Palmieri MG, Colonnese C, Bozzao L, Caramia MD: Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation. Magn Reson Imaging 2009;27:1360-1369.
7.
Shimamura N, Ohkuma H, Ogane K, Manabe H, Yagihashi A, Kikkawa T, Suzuki S: Displacement of central sulcus in cerebral arteriovenous malformation situated in the peri-motor cortex as assessed by magnetoencephalographic study. Acta Neurochir (Wien) 2004;146:363-368, discussion 368.
8.
Flickinger JC, Kondziolka D, Lunsford LD, Kassam A, Phuong LK, Liscak R, Pollock B: Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys 2000;46:1143-1148.
9.
Aoyama H, Kamada K, Shirato H, Takeuchi F, Kuriki S, Iwasaki Y, Miyasaka K: Integration of functional brain information into stereotactic irradiation treatment planning using magnetoencephalography and magnetic resonance axonography. Int J Radiat Oncol Biol Phys 2004;58:1177-1183.
10.
Spetzler RF, Martin NA: A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476-483.
11.
Lunsford LD, Niranjan A, Kano H, Kondziolka D: The technical evolution of gamma knife radiosurgery for arteriovenous malformations. Prog Neurol Surg 2013;27:22-34.
12.
Kano H, Kondziolka D, Flickinger JC, Yang H-C, Flannery TJ, Awan NR, Niranjan A, Novotny J, Lunsford LD: Stereotactic radiosurgery for arteriovenous malformations. 3. Outcome predictors and risks after repeat radiosurgery. J Neurosurg 2012;116:21-32.
13.
Hadjipanayis CG, Levy EI, Niranjan A, Firlik AD, Kondziolka D, Flickinger JC, Lunsford LD: Stereotactic radiosurgery for motor cortex region arteriovenous malformations. Neurosurgery 2001;48:70-76, discussion 76-77.
14.
Andrade-Souza YM, Ramani M, Scora D, Tsao MN, Ter Brugge K, Schwartz ML: Radiosurgical treatment for rolandic arteriovenous malformations. J Neurosurg 2006;105:689-697.
15.
O'Laoire SA: Microsurgical treatment of arteriovenous malformations in critical areas of the brain. Br J Neurosurg 1995;9:347-360.
16.
Da Pian R, Pasqualin A, Scienza R, Vivenza C: Microsurgical treatment of ten arteriovenous malformations in critical areas of the cerebrum. J Microsurg 1980;1:305-320.
17.
Bambakidis NC, Sunshine JL, Faulhaber PF, Tarr RW, Selman WR, Ratcheson RA: Functional evaluation of arteriovenous malformations. Neurosurg Focus 2001;11:e2.
18.
Rezai AR, Hund M, Kronberg E, Zonenshayn M, Cappell J, Ribary U, Kall B, Llinás R, Kelly PJ: The interactive use of magnetoencephalography in stereotactic image-guided neurosurgery. Neurosurgery 1996;39:92-102.
19.
Rezai AR, Hund M, Kronberg E, Deletis V, Zonenshayn M, Cappell J, Ribary U, Llinás R, Kelly PJ: Introduction of magnetoencephalography to stereotactic techniques. Stereotact Funct Neurosurg 1995;65:37-41.
20.
Koga T, Shin M, Maruyama K, Kamada K, Ota T, Itoh D, Kunii N, Ino K, Aoki S, Masutani Y, Igaki H, Onoe T, Saito N: Integration of corticospinal tractography reduces motor complications after radiosurgery. Int J Radiat Oncol Biol Phys 2012;83:129-133.
21.
Koga T, Maruyama K, Kamada K, Ota T, Shin M, Itoh D, Kunii N, Ino K, Terahara A, Aoki S, Masutani Y, Saito N: Outcomes of diffusion tensor tractography-integrated stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012;82:799-802.
22.
Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Goldman S: Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. J Nucl Med 2004;45:1146-1154.
23.
Stancanello J, Cavedon C, Francescon P, Causin F, Avanzo M, Colombo F, Cerveri P, Ferrigno G, Uggeri F: BOLD fMRI integration into radiosurgery treatment planning of cerebral vascular malformations. Med Phys 2007;34:1176-1184.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.